Exostar, a Herndon, Va.-based information technology company offering cloud-based solutions that enable secure, cost-effective business-to-business collaboration, has launched its new turn-key, Software-as-a-Service (SaaS) identity proofing and second factor credential authentication solution, ProviderPass. eClinicalWorks, a Westborough, Mass.-based provider of ambulatory healthcare IT solutions, has selected ProviderPass to expand its comprehensive electronic health records (EHR) product suite to include electronic prescribing of controlled substances (EPCS).
The Drug Enforcement Administration (DEA) created strict technical EPCS requirements to help combat the prescription drug abuse epidemic. Healthcare providers who wish to e-prescribe controlled substances must complete a stringent identity proofing process and present a high-assurance digital credential to verify their identity and digital signature when they submit a prescription.
With ProviderPass, eClinicalWorks will deliver easy-to-use, innovative, affordable EPCS functionality to its customers, which include large hospital systems; large and small health systems; large, medium, small and solo provider practices; correctional health services; and community health centers throughout the U.S.
Exostar’s ProviderPass includes remote identity proofing conducted in conjunction with Experian or via live web cam video. Individuals purchase a one-time password (OTP) hardware token through Exostar’s web store. eClinicalWorks customers use its EHR system in tandem with an activated OTP token to seamlessly e-prescribe controlled substances.
Exostar is a full-service Credential Service Provider certified by the SAFE-BioPharma Association to meet the National Institute of Standards and Technology’s 800-63 level three standard mandated by the DEA. Because SAFE-BioPharma is a U.S. government-approved trust framework provider, ProviderPass also aligns with U.S. Federal Identity and Credentialing Access Management (FICAM) requirements.